Anti-Human CD70 T-Cell Injection: Clinical Trials

1 trial of Anti-Human CD70 T-Cell Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Anti-Human CD70 T-Cell Injection: new trials by email Literature Review of Anti-Human CD70 T-Cell Injection trials Research Report on Anti-Human CD70 T-Cell Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer
Anti-Human CD70 T-Cell Injection - Renal Cell Carcinoma (RCC)
Phase 1RecruitingHrain Biotechnology Co., Ltd.182026-06-302026-07-02

Conditions studied

Carcinoma, Renal Cell (1)

Sponsors

Hrain Biotechnology Co., Ltd. (1)

Countries

China (1)